MOLECULAR LINKS BETWEEN ALZHEIMER'S DISEASE AND DIABETES MELLITUS

被引:163
作者
Yang, Y. [1 ]
Song, W. [1 ]
机构
[1] Univ British Columbia, Grad Program Neurosci, Brain Res Ctr, Townsend Family Labs,Dept Psychiat, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
Alzheimer's disease; diabetes; molecular links; ISLET AMYLOID POLYPEPTIDE; INSULIN-DEGRADING ENZYME; GLYCATION END-PRODUCTS; CYTOCHROME-C-OXIDASE; TRANSGENIC MOUSE MODEL; HIPPOCAMPAL SYNAPTIC PLASTICITY; RANDOMIZED CONTROLLED-TRIAL; GROWTH-FACTOR EXPRESSION; FREE-RADICAL GENERATION; A-BETA ACCUMULATION;
D O I
10.1016/j.neuroscience.2013.07.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Substantial epidemiological evidence shows an increased risk for developing Alzheimer's disease (AD) in people with diabetes. Yet the underlying molecular mechanisms still remain to be elucidated. This article reviews the current studies on common pathological processes of Alzheimer's disease and diabetes with particular focus on potential mechanisms through which diabetes affects the initiation and progression of Alzheimer's disease. Impairment of insulin signaling, inflammation, oxidative stress, mitochondrial dysfunction, advanced glycation end products, APOE epsilon 4 and cholesterol appear to be important mediators and are likely to act synergistically in promoting AD pathology. (c) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:140 / 150
页数:11
相关论文
共 213 条
[71]   HYDROXYL RADICAL PRODUCTION AND AUTOXIDATIVE GLYCOSYLATION - GLUCOSE AUTOXIDATION AS THE CAUSE OF PROTEIN DAMAGE IN THE EXPERIMENTAL GLYCATION MODEL OF DIABETES-MELLITUS AND AGING [J].
HUNT, JV ;
DEAN, RT ;
WOLFF, SP .
BIOCHEMICAL JOURNAL, 1988, 256 (01) :205-212
[72]   The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease [J].
Hutter-Paier, B ;
Huttunen, HJ ;
Puglielli, L ;
Eckman, CB ;
Kim, DY ;
Hofmeister, A ;
Moir, RD ;
Domnitz, SB ;
Frosch, MP ;
Windisch, M ;
Kovacs, DM .
NEURON, 2004, 44 (02) :227-238
[73]   The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles [J].
Janson, J ;
Ashley, RH ;
Harrison, D ;
McIntyre, S ;
Butler, PC .
DIABETES, 1999, 48 (03) :491-498
[74]   Increased risk of type 2 diabetes in Alzheimer disease [J].
Janson, J ;
Laedtke, T ;
Parisi, JE ;
O'Brien, P ;
Petersen, RC ;
Butler, PC .
DIABETES, 2004, 53 (02) :474-481
[75]   Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer's disease [J].
Jo, Dong-Gyu ;
Arumugam, Thiruma V. ;
Woo, Ha-Na ;
Park, Jong-Sung ;
Tang, Sung-Chun ;
Mughal, Mohamed ;
Hyun, Dong-Hoon ;
Park, Jun-Hyung ;
Choi, Yun-Hyung ;
Gwon, A-Ryeong ;
Camandola, Simonetta ;
Cheng, Aiwu ;
Cai, Huaibin ;
Song, Weihong ;
Markesbery, William R. ;
Mattson, Mark P. .
NEUROBIOLOGY OF AGING, 2010, 31 (06) :917-925
[76]   Tau phosphorylation in neuronal cell function and dysfunction [J].
Johnson, GVW ;
Stoothoff, WH .
JOURNAL OF CELL SCIENCE, 2004, 117 (24) :5721-5729
[77]   Regulation by insulin of a unique neuronal Ca2+ pool and of neuropeptide secretion [J].
Jonas, EA ;
Knox, RJ ;
Smith, TCM ;
Wayne, NL ;
Connor, JA ;
Karzmarek, LK .
NATURE, 1997, 385 (6614) :343-346
[78]   Apolipoprotein E: Isoform Specific Differences in Tertiary Structure and Interaction with Amyloid-β in Human Alzheimer Brain [J].
Jones, Phillip B. ;
Adams, Kenneth W. ;
Rozkalne, Anete ;
Spires-Jones, Tara L. ;
Hshieh, Tammy T. ;
Hashimoto, Tadafumi ;
von Armin, Christine A. F. ;
Mielke, Mathew ;
Bacskai, Brian J. ;
Hyman, Bradley T. .
PLOS ONE, 2011, 6 (01)
[79]   EVIDENCE OF COSECRETION OF ISLET AMYLOID POLYPEPTIDE AND INSULIN BY BETA-CELLS [J].
KAHN, SE ;
DALESSIO, DA ;
SCHWARTZ, MW ;
FUJIMOTO, WY ;
ENSINCK, JW ;
TABORSKY, GJ ;
PORTE, D .
DIABETES, 1990, 39 (05) :634-638
[80]  
Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555